Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for IMNN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 6.864M
March 31, 2026 4.794M
December 31, 2025 8.781M
September 30, 2025 5.251M
June 30, 2025 4.729M
March 31, 2025 2.872M
December 31, 2024 5.873M
September 30, 2024 10.31M
June 30, 2024 5.307M
March 31, 2024 9.809M
December 31, 2023 15.70M
September 30, 2023 19.38M
June 30, 2023 24.01M
March 31, 2023 33.43M
December 31, 2022 34.25M
September 30, 2022 37.35M
June 30, 2022 42.11M
March 31, 2022 41.31M
December 31, 2021 49.39M
September 30, 2021 54.51M
June 30, 2021 58.36M
March 31, 2021 52.76M
December 31, 2020 17.16M
September 30, 2020 18.34M
June 30, 2020 25.45M
Date Value
March 31, 2020 15.63M
December 31, 2019 14.86M
September 30, 2019 18.81M
June 30, 2019 21.72M
March 31, 2019 23.74M
December 31, 2018 27.61M
September 30, 2018 21.95M
June 30, 2018 26.20M
March 31, 2018 20.70M
December 31, 2017 24.17M
September 30, 2017 2.685M
June 30, 2017 3.629M
March 31, 2017 4.470M
December 31, 2016 4.304M
September 30, 2016 8.700M
June 30, 2016 14.47M
March 31, 2016 14.31M
December 31, 2015 20.06M
September 30, 2015 24.35M
June 30, 2015 30.73M
March 31, 2015 30.01M
December 31, 2014 36.86M
September 30, 2014 43.61M
June 30, 2014 49.77M
March 31, 2014 51.86M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Phio Pharmaceuticals Corp. 13.00M
Agenus, Inc. 18.74M
Amgen, Inc. 13.99B
Anika Therapeutics, Inc. 38.41M
BioCryst Pharmaceuticals, Inc. 353.05M